NIA Loves OGO and RHT

NIA loves Organto Foods (TSXV: OGO) or OGOFF on the U.S. OTC due to its explosive revenue growth, which is very similar to NIA's #1 largest gaining stock suggestion of all-time Voyager Digital (CSE: VYGR) and very rare for a non-technology company. While VYGR's CEO Steve Ehrlich previously built Lightspeed Financial (a company he co-founded in 2006 and led as CEO) into the third largest stock/option brokerage in the United States by 2009 when it was executing 450,000 trades per day and has now repeated his success at VYGR by turning it from a $52 million market cap company at the time of NIA's June 10th suggestion to a multi-billion dollar market cap company today... OGO's Chairman and Co-CEO Steve Bromley previously built SunOpta (STKL) into one of the NASDAQ's largest organic food companies with a multi-billion dollar enterprise value today!

With STKL breaking out once again today it is already up by 34.02% in 2021 or 8.57X more than the NASDAQ Composite's year-to-date gain of only 3.97%! In fact, STKL in 2021 is now up 69.43X more than Tesla (TSLA)! Shockingly, STKL is even up 3.54X more than Cathie 'the GOAT' Wood's ARK Innovation (ARKK) ETF in 2021!

As amazingly strong as STKL has performed, because Bromley is no longer running the company, STKL's revenue last quarter declined by 2.68% quarter-over-quarter! With Bromley now leading OGO its revenue last quarter grew by 26.49% quarter-over-quarter! We can't stress this enough... OGO's quarter-over-quarter revenue growth rate is about to greatly accelerate when OGO reports its 4Q 2020 and year-end 2020 results in the very near-future! We will most likely see OGO's quarter-over-quarter revenue growth rate more than triple from the previous quarter! On a year-over-year basis, OGO's revenue growth rate will likely accelerate by an even more incredible amount! This isn't speculation this is all based on publicly available information but very few investors are aware of its existence!

NIA also loves Reliq Health Technologies (TSXV: RHT) or RQHTF on the U.S. OTC because not only did RHT recently announce that they expect revenue to consistently increase month-over-month moving forward... but RHT is now backing itself up with multiple major contract announcements in recent weeks that will each result in RHT earning consistent, recurring monthly revenue from many thousands of Medicare, Medicaid and private insurance patients who will now enjoy an improved quality of life due to RHT's disruptive remote healthcare technology! Teledoc (TDOC) may be the most well-known company in this space with the highest market cap (at US$36 billion), but that doesn't mean TDOC has the best technology! Many medical professionals are beginning to figure out that RHT's iUGO Care platform is the best remote healthcare technology available on the market for the treatment of long-term chronic diseases.

Today, RHT announced that it has signed a new contract with a US Nephrology practice in Texas to use RHT's proprietary iUGO Care platform to monitor Chronic Kidney Disease patients and help improve their health outcomes! Using RHT's highly scalable iUGO Care platform, Nephrologists can help monitor medication compliance and manage patients’ co-morbidities like diabetes and high blood pressure, helping to reduce or prevent further damage to the kidneys that could lead to End Stage Renal Disease and the need for costly and disruptive interventions like dialysis or a kidney transplant. RHT will begin onboarding patients next week and expects to have at least 5,000 kidney disease patients on the platform by the end of this calendar year at an average revenue of US$65 per patient per month!

RHT also has an amazing management team with RHT's CEO Dr. Lisa Crossley having previously been CEO of VitalHub, CEO of Quantum Dental Technologies, and President & CEO of Natrix Separations (acquired by Merck).

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from OGO of USD$30,000 cash for a six-month marketing contract. NIA has received compensation from RHT of USD$40,000 cash for a six-month marketing contract. NIA has received compensation from VYGR of USD$60,000 cash for a one-year marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.